查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1441192

全球抗菌藥物敏感性測試市場規模、佔有率、成長分析（按測試類型、最終用戶、產品類型）- 產業預測，2023-2030 年

Global Antimicrobial Susceptibility Testing Market Size, Share, Growth Analysis, By Test type, By End user, By Product type - Industry Forecast 2023-2030
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球抗菌藥物敏感性測試市場規模為36億美元，將從2023年的37.9億美元成長到2031年的56.8億美元，預測期內（2024-2031年）複合年成長率為5.20%。

在抗菌藥物抗藥性的普遍存在以及對有效治療策略的需求不斷成長的推動下，全球抗菌藥物敏感性測試 (AST) 市場正在顯著成長。 AST 在幫助臨床醫生選擇合適的抗菌療法、確保最佳治療結果以及對抗抗藥性病原體的增殖方面發揮著至關重要的作用。 AST 的主要目的是提供準確、及時的微生物對各種抗生素敏感性的資訊。 AST 使醫療保健專業人員能夠就抗生素選擇、劑量和治療持續時間做出明智的決定，從而有助於有效管理感染疾病。透過識別最有效的抗生素，AST 有助於制定個人化治療計劃，降低治療失敗的風險，並支持抗菌藥物管理工作。有幾個關鍵因素推動抗菌藥物敏感性測試市場的成長。抗菌素抗藥性負擔日益加重，導致發病率、死亡率和醫療費用增加，從而推動了對 AST 的需求。此外，感染疾病爆發和醫院感染的迅速增加，以及人們對標靶治療需求的認知不斷增強，正在推動市場擴張。 AST 技術、自動化以及分子診斷與 AST 系統的整合的快速採用將進一步刺激市場成長。然而，在資源有限的環境中，先進的 AST 方法的獲取有限、先進測試技術的實施成本較高、測試結果解釋的複雜性以及測試方法標準化的挑戰。傳統的 AST 方法可能會阻礙市場成長。抗菌藥物敏感性測試市場的主要趨勢包括快速、高精度 AST 系統市場的開拓、用於資料分析的人工智慧 (AI) 和機器學習演算法的引入、以及人工智慧 (AI) 和機器學習的引入用於同時檢測多種抗菌藥物抗藥性模式的演算法，其中包括對多重檢測的更多關注。市場上還存在著巨大的成長和創新機會，包括對照護現場檢測的需求不斷增加、在實驗室中採用自動化 AST 系統以及在感染疾病管理中更加重視個人化醫療。診斷公司、研究機構和醫療機構之間的合作有望加速AST技術的進步並擴大其市場範圍。

目錄

執行摘要

  • 市場概況
  • 轉型

調查方法

  • 資訊採購
  • 次要和主要資料來源
  • 市場規模估算
  • 市場假設與限制

母市場分析

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務

主要市場考察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • Start-Ups分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及前景

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 監管環境
  • 波特的分析
  • 對未來中斷的特殊考慮

全球抗菌藥物敏感性測試市場：依測試類型

  • 市場概況
  • 表現型測試
  • 基因型檢測
  • 快速診斷

全球抗菌藥物敏感性測試市場：按最終用戶分類

  • 市場概況
  • 醫院和診斷實驗室
  • 研究和學術機構
  • 製藥和生物技術公司

全球抗菌藥物敏感性測試市場：依產品類型

  • 市場概況
  • 裝置
  • 試劑和套件
  • 軟體和服務

全球抗菌藥物敏感性測試市場規模：按地區分類

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位（2021年）
  • 主要市場參與者所採取的策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率（2021年）

主要企業簡介

  • 賽默飛世爾科技公司（美國）
  • Bio-Rad 實驗室公司（美國）
  • 丹納赫公司（美國）
  • 貝克頓迪金森公司（美國）
  • 生物梅里埃公司（法國）
  • 羅氏診斷（瑞士）
  • 雅培實驗室（美國）
  • 布魯克公司（美國）
  • 默克公司（德國）
  • 安捷倫科技公司（美國）
  • ConvaTec Group plc（英國）
  • 造父變星（美國）
  • HiMedia Laboratories Pvt. Ltd.（印度）
  • Liofilchem srl（義大利）
  • 加速診斷公司（美國）
  • 創意診斷（美國）
  • Bio-Rad 實驗室（美國）
  • 共生（英國）
  • ELITech集團（法國）
  • QIAGEN NV（德國）
簡介目錄
Product Code: SQMIG35B2120

Global Antimicrobial Susceptibility Testing Market size was valued at USD 3.60 Billion in 2022 and is poised to grow from USD 3.79 Billion in 2023 to USD 5.68 Billion by 2031, at a CAGR of 5.20% during the forecast period (2024-2031).

The global Antimicrobial Susceptibility Testing (AST) Market is experiencing notable growth, fueled by the rising prevalence of antimicrobial resistance and the imperative for effective treatment strategies. AST plays a pivotal role in assisting clinicians in choosing appropriate antimicrobial therapies, ensuring optimal treatment outcomes, and addressing the surge of drug-resistant pathogens. Its primary objective is to furnish accurate and timely information on microorganisms' susceptibility to various antibiotics. AST empowers healthcare professionals to make informed decisions regarding antibiotic selection, dosage, and treatment duration, contributing to the proficient management of infectious diseases. By identifying the most effective antibiotics, AST facilitates personalized treatment plans, mitigates the risk of treatment failure, and supports antimicrobial stewardship initiatives. Several key factors are propelling the growth of the antimicrobial susceptibility testing market. The escalating burden of antimicrobial resistance, leading to increased morbidity, mortality, and healthcare costs, propels the demand for AST. Furthermore, the upsurge in infectious disease outbreaks, hospital-acquired infections, and heightened awareness of the necessity for targeted therapies drive market expansion. The introduction of rapid AST methods, automation, and the integration of molecular diagnostics into AST systems further stimulate market growth. Nevertheless, challenges such as limited access to advanced AST methods in resource-constrained settings, high implementation costs for sophisticated testing technologies, the intricacy of interpreting test results, difficulties in standardizing testing methods, and the time-consuming nature of traditional AST methods may impede market growth. Key trends in the antimicrobial susceptibility testing market involve the development of rapid and precise AST systems, the incorporation of artificial intelligence (AI) and machine learning algorithms for data analysis, and an increased focus on multiplex testing to detect multiple drug resistance patterns simultaneously. The market also presents substantial opportunities for growth and innovation, including the rising demand for point-of-care testing, the adoption of automated AST systems in laboratories, and the growing emphasis on personalized medicine in infectious disease management. Collaborations between diagnostic companies, research institutions, and healthcare organizations are anticipated to drive advancements in AST technologies and expand market reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antimicrobial Susceptibility Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antimicrobial Susceptibility Testing Market Segmental Analysis

Global Antimicrobial Susceptibility Testing Market is segmented on the basis of test type, end user, product type, and region. By test type, the market is segmented into phenotypic testing, genotypic testing, and rapid testing. By end user, the market is segmented into hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies. By product type, the market is segmented into Instruments, reagents and kits, and software and services. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Antimicrobial Susceptibility Testing Market

The surge in antimicrobial resistance stands out as a major catalyst for the Antimicrobial Susceptibility Testing (AST) market. The advent of drug-resistant pathogens poses a grave and widespread threat to public health. A noteworthy example is the escalating prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections, underscoring the critical necessity for precise AST. This need arises to guide clinicians in making informed decisions regarding the selection of suitable antibiotics for effective treatment.

Restraints in the Global Antimicrobial Susceptibility Testing Market

Limited access to advanced Antimicrobial Susceptibility Testing (AST) technologies in resource-constrained settings poses a hindrance to market growth. For instance, low-income countries may encounter difficulties in adopting automated AST systems due to their elevated costs and the requirement for adequately trained personnel.

Market Trends of the Global Antimicrobial Susceptibility Testing Market

The incorporation of artificial intelligence (AI) and machine learning algorithms for analyzing Antimicrobial Susceptibility Testing (AST) data is an expanding trend. These technologies play a crucial role in deciphering intricate datasets, enhancing the precision, and expediting the interpretation of AST results. An illustrative instance is the AI-powered platform DeepAMR, which utilizes machine learning to forecast bacterial susceptibility to antibiotics by leveraging genomic data.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Antimicrobial Susceptibility Testing Market by Test type

  • Market Overview
  • Phenotypic testing
  • genotypic testing
  • and rapid testing

Global Antimicrobial Susceptibility Testing Market by End user

  • Market Overview
  • Hospitals and diagnostic laboratories
  • research and academic institutes
  • and pharmaceutical and biotechnology companies

Global Antimicrobial Susceptibility Testing Market by Product type

  • Market Overview
  • Instruments
  • reagents and kits
  • and software and services

Global Antimicrobial Susceptibility Testing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiMedia Laboratories Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Liofilchem s.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accelerate Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synbiosis (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ELITechGroup (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V. (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments